
Labiana Health reports 17% growth in adjusted EBITDA and 12% in revenue
Labiana closes H1 2025 with €7.7M in adjusted EBITDA and €39.2M in revenue. In 2024, it was the top-performing BME Growth stock with a +136.80% increase. MADRID, MADRID, SPAIN, August 5, 2025 /EINPresswire.com/ -- Labiana Health, the Spanish …